[HTML][HTML] The progress in the treatment of hepatocellular carcinoma with portal vein tumor thrombus
F Luo, M Li, J Ding, S Zheng - Frontiers in Oncology, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is one of most prevalent cancer and is a serious healthcare
issue worldwide. Portal vein tumor thrombus (PVTT) is a frequent complication and remains …
issue worldwide. Portal vein tumor thrombus (PVTT) is a frequent complication and remains …
Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis
Portal vein tumor thrombosis (PVTT) is one of the most common complications in
hepatocellular carcinoma (HCC). HCC with PVTT usually indicates poor prognosis, which …
hepatocellular carcinoma (HCC). HCC with PVTT usually indicates poor prognosis, which …
[HTML][HTML] PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in …
K Su, L Guo, K He, M Rao, J Zhang, X Yang… - Frontiers in …, 2022 - frontiersin.org
Aim A programmed death 1 (PD-1) inhibitor coupled with radiotherapy and antiangiogenic
therapy is a potential therapeutic strategy for advanced hepatocellular carcinoma (HCC). We …
therapy is a potential therapeutic strategy for advanced hepatocellular carcinoma (HCC). We …
[HTML][HTML] Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter …
K Su, F Wang, X Li, H Chi, J Zhang, K He… - Frontiers in …, 2023 - frontiersin.org
Background The optimal local treatment for HCC with tumor diameter≥ 5 cm is not well
established. This research evaluated the effectiveness of external beam radiation therapy …
established. This research evaluated the effectiveness of external beam radiation therapy …
[HTML][HTML] Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score …
K Su, T Gu, K Xu, J Wang, H Liao, X Li, L Wen… - Hepatology …, 2022 - Springer
Background The optimal locoregional treatment for hepatocellular carcinoma (HCC) patients
with portal vein tumor thrombus (PVTT) is unclear. This study aimed to investigate the …
with portal vein tumor thrombus (PVTT) is unclear. This study aimed to investigate the …
The multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus
G Qiu, K Xie, Z Jin, C Jiang, H Liu, H Wan… - Bioscience …, 2021 - jstage.jst.go.jp
Portal vein tumor thrombus (PVTT) is one of the most common complications of
hepatocellular carcinoma (HCC), which refers to the advanced stage of HCC and indicates …
hepatocellular carcinoma (HCC), which refers to the advanced stage of HCC and indicates …
Radionuclide‐Labeled Microspheres for Radio‐Immunotherapy of Hepatocellular Carcinoma
Brachytherapy, including radioactive seed implantation (RSI) and transarterial radiation
therapy embolization (TARE), is an important treatment modality for advanced …
therapy embolization (TARE), is an important treatment modality for advanced …
[HTML][HTML] Prognostic value of skeletal muscle loss in patients with hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
K Oura, A Morishita, J Tani, T Nomura, T Manabe… - Cancers, 2023 - mdpi.com
Simple Summary Although reduced skeletal muscle mass affects therapeutic efficacy and
adverse events in various therapies for hepatocellular carcinoma (HCC), there are no …
adverse events in various therapies for hepatocellular carcinoma (HCC), there are no …
Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC
Y Liu, X Zhang, B Yang, H Zhuang, H Guo, W Wei, Y Li… - Cancer Research, 2018 - AACR
Invasion and intrahepatic metastasis are major factors of poor prognosis in patients with
hepatocellular carcinoma (HCC). In this study, we show that increased Src homolog and …
hepatocellular carcinoma (HCC). In this study, we show that increased Src homolog and …
Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation
Z Yang, R Zou, Y Zheng, J Qiu, J Shen, Y Liao… - European …, 2019 - Springer
Objective To study lipiodol deposition in portal vein tumour thrombus (PVTT) in predicting
the treatment outcome of hepatocellular carcinoma (HCC) patients after transarterial …
the treatment outcome of hepatocellular carcinoma (HCC) patients after transarterial …